About Gameto
Gameto is a company based in United States founded in 2020 by Dina Radenkovic and Martin Varsavsky. Gameto has raised $127 million across 5 funding rounds from investors including RA Capital, FJ Labs and Plum Alley Investments. Gameto offers products and services including Fertilo. Gameto operates in a competitive market with competitors including Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Naari, among others.
- Headquarter United States
- Founders Dina Radenkovic, Martin Varsavsky
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gameto, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$127 M (USD)
in 5 rounds
-
Latest Funding Round
$44 M (USD), Series C
Aug 12, 2025
-
Investors
RA Capital
& 28 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gameto
Gameto offers a comprehensive portfolio of products and services, including Fertilo.
iPSC-based treatment to enhance IVF success and reduce hormone use
People of Gameto
Unlock access to complete
Unlock access to complete
Funding Insights of Gameto
Gameto has successfully raised a total of $127M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $44 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $44.0M
-
First Round
First Round
(01 Mar 2020)
- Investors Count 29
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Series C - Gameto | Valuation | Overwater Ventures | |
| May, 2024 | Amount | Series B - Gameto | Valuation | Two Sigma Ventures , RA Capital Management | |
| Sep, 2022 | Amount | Series A - Gameto | Valuation | Insight Partners , Myelin |
Investors in Gameto
Gameto has secured backing from 29 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include RA Capital, FJ Labs and Plum Alley Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in tech sectors are managed by the firm.
|
Founded Year | Domain | Location | |
|
Investment firm scaling software and technology companies from early to late stages.
|
Founded Year | Domain | Location | |
|
Future Ventures is focused on early-stage venture capital investments.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gameto
Financial Statements - Gameto
Gameto Comparisons
Competitors of Gameto
Gameto operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Naari, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| domain | founded_year | HQ Location |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| domain | founded_year | HQ Location |
Women care medicines are manufactured by Naari in India.
|
Frequently Asked Questions about Gameto
Gameto was founded in 2020.
Gameto is headquartered in United States.
Dina Radenkovic is the current CEO of Gameto. They have also founded this company.
Gameto is a funded company, having raised a total of $127M across 5 funding rounds to date. The company's 1st funding round was a Series A of $17M, raised on Mar 01, 2020.
Gameto was founded in 2020 in the United States as a biotechnology company. Therapeutics targeting fertility and menopause are developed to address womens health needs. Operations center on research and development of innovative treatments in these areas. The company is co-founded by Dina Radenkovic, who serves as CEO, and Martin Varsavsky. Focus remains on advancing solutions within the reproductive health sector.
Gameto's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Gameto offers Fertilo.
Gameto has 29 investors. Key investors include RA Capital, FJ Labs, Plum Alley Investments, Two Sigma Ventures, and Insight Partners.